Expression of the CTLA-4 ligand CD86 (B7.2) on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in chronic myeloid leukemiaA. Burchert,S. Inselmann,S. Saußele,C. T. Dietz,M. C. Müller,E. Eigendorff,C. A. Brendel,S. K. Metzelder,Tim H. Brümmendorf,Cornelius F. Waller,J. Dengler,M. E. Goebeler,R. Herbst,G. Freunek,H. Stefan,T. Illmer,Y. Wang,Thoralf Lange,F. Finkernagel,R. Hehlmann,M. Huber,Andreas Neubauer, Andreas Hochhaus,J. Guilhot,F. X. Mahon,M. Pfirrmann,C. SchützONCOLOGY RESEARCH AND TREATMENT（2016）引用 1|浏览60暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
